Matthias Kretzler Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

1/2022	Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes.
1/2021	Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes.
1/2021	Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease.
1/2021	Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
1/2021	Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting.
1/2021	Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy.
12/2020	SARS-CoV-2 receptor networks in diabetic and COVID-19-associated kidney disease.
1/2020	JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy.
1/2020	Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
1/2020	A role for NPY-NPY2R signaling in albuminuric kidney disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Kretzler Research Topics

Disease

48	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 07/2003
34	Proteinuria 01/2022 - 05/2001
25	Inflammation (Inflammations) 01/2022 - 05/2002
24	Fibrosis (Cirrhosis) 04/2022 - 01/2002
19	Albuminuria 04/2022 - 05/2001
19	Chronic Renal Insufficiency 01/2021 - 12/2007
17	Kidney Diseases (Kidney Disease) 01/2021 - 05/2004
16	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 02/2022 - 07/2003
14	Nephrotic Syndrome (Syndrome, Nephrotic) 11/2021 - 01/2004
12	Type 2 Diabetes Mellitus (MODY) 01/2021 - 02/2009
12	Lupus Nephritis 01/2019 - 03/2004
10	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2020 - 05/2003
9	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2020 - 05/2003
8	Disease Progression 01/2021 - 10/2017
8	Glomerulonephritis 11/2019 - 05/2001
8	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 05/2009
7	Renal Insufficiency (Renal Failure) 12/2018 - 06/2004
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2013
6	Hyperglycemia 01/2022 - 10/2008
6	Infections 12/2021 - 02/2003
6	IGA Glomerulonephritis (IGA Nephropathy) 01/2020 - 05/2003
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018 - 03/2004
5	Hypertension (High Blood Pressure) 01/2021 - 12/2004
4	Vasculitis (Vasculitides) 11/2021 - 10/2010
4	Atrophy 03/2016 - 12/2004
4	Diabetic Neuropathies (Diabetic Neuropathy) 09/2015 - 10/2008
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 01/2016
3	Diabetes Complications 01/2021 - 01/2013
3	Wounds and Injuries (Trauma) 01/2021 - 01/2004
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 08/2014
3	Hereditary Nephritis (Alport Syndrome) 12/2018 - 06/2010
3	Hypoxia (Hypoxemia) 01/2017 - 06/2007
3	Segmental glomerulosclerosis 03/2015 - 09/2003
3	Nephritis 11/2014 - 07/2003
3	Nephrosclerosis 11/2010 - 07/2003
3	Atherosclerosis 10/2010 - 01/2009
3	Neoplasms (Cancer) 09/2006 - 06/2002
2	Sclerosis 01/2020 - 12/2004
2	Heart Failure 01/2019 - 10/2018
2	Insulin Resistance 01/2017 - 08/2009
2	Wilms Tumor (Wilm's Tumor) 02/2015 - 11/2003
2	Prostatic Neoplasms (Prostate Cancer) 03/2012 - 06/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2011 - 08/2009

Drug/Important Bio-Agent (IBA)

33	Messenger RNA (mRNA)IBA 01/2021 - 01/2002
29	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
26	Biomarkers (Surrogate Marker)IBA 04/2022 - 04/2012
14	CreatinineIBA 11/2021 - 08/2003
10	Antigen-Antibody Complex (Immune Complex)IBA 10/2017 - 05/2001
8	Epidermal Growth Factor (EGF)IBA 01/2021 - 06/2007
8	ChemokinesIBA 01/2012 - 05/2001
7	RNA (Ribonucleic Acid)IBA 02/2022 - 06/2002
7	Streptozocin (Streptozotocin)FDA Link 01/2021 - 10/2008
7	AlbuminsIBA 12/2019 - 10/2010
6	LipidsIBA 10/2021 - 08/2009
6	Biological ProductsIBA 01/2021 - 12/2008
6	CytokinesIBA 01/2020 - 08/2003
5	Insulin (Novolin)FDA Link 01/2022 - 10/2008
5	Apolipoprotein L1IBA 01/2022 - 02/2015
5	CollagenIBA 10/2019 - 01/2002
5	Pharmaceutical PreparationsIBA 10/2018 - 01/2002
5	Transforming Growth Factor beta (TGF-beta)IBA 01/2018 - 06/2004
5	NPHS2 proteinIBA 05/2009 - 11/2003
5	DNA (Deoxyribonucleic Acid)IBA 05/2005 - 06/2002
5	BX 471IBA 04/2005 - 01/2002
5	Chemokine ReceptorsIBA 06/2004 - 05/2001
4	Peptides (Polypeptides)IBA 01/2022 - 12/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2013
4	NAD (NADH)IBA 01/2021 - 09/2015
4	Janus KinasesIBA 01/2020 - 02/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2004
4	Immunoglobulin A (IgA)IBA 01/2019 - 07/2003
4	CholesterolIBA 12/2018 - 11/2013
4	Pioglitazone (Actos)FDA Link 01/2017 - 08/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2010 - 06/2004
4	Chemokine CCL5IBA 01/2009 - 05/2001
3	LigandsIBA 01/2021 - 05/2008
3	CyclodextrinsIBA 12/2018 - 11/2013
3	Toll-Like Receptor 3IBA 01/2012 - 05/2005
3	Matrix Metalloproteinases (MMPs)IBA 04/2011 - 09/2004
3	nephrinIBA 05/2009 - 11/2003
3	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2006 - 03/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2021 - 01/2016
2	Retinaldehyde (Retinal)IBA 10/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2015
2	Growth Differentiation Factor 15IBA 10/2018 - 07/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 08/2009
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018 - 01/2018
2	Fibronectins (Fibronectin)IBA 10/2017 - 05/2006
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017 - 08/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2012
2	Fibroblast Growth Factor-23IBA 01/2017 - 07/2012
2	C-Reactive ProteinIBA 01/2017 - 07/2012
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2012 - 05/2005
2	Interleukin-1 (Interleukin 1)IBA 12/2011 - 10/2010
2	Mechanistic Target of Rapamycin Complex 1IBA 06/2011 - 06/2011
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 11/2010 - 06/2005

Therapy/Procedure

16	Therapeutics 12/2021 - 04/2011
5	Nephrectomy 01/2022 - 05/2005
5	Precision Medicine 01/2021 - 03/2006
2	Remission Induction 08/2014 - 04/2011